Calabrese Salvatore 4
4 · Gain Therapeutics, Inc. · Filed Mar 27, 2023
Insider Transaction Report
Form 4
Calabrese Salvatore
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-03-23+50,000→ 50,000 totalExercise: $4.84Exp: 2033-03-23→ Common Stock (50,000 underlying) - Award
Restricted Stock Units
2023-03-23+25,000→ 25,000 total→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]The shares underlying the option shall vest 25% on March 23, 2024 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F3]The RSUs shall vest 25% on March 23, 2024 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.